Scientists Have Discovered A New Method Of Detecting Cancer

Scientists Have Discovered A New Method Of Detecting Cancer.
A redone examination marketed as an alternative to a mammogram for breast cancer detection is not an remarkable screening TOOL, US health officials say. With the nipple aspirate test, a tit pump collects fluid from a woman's nipple. The fluid is then examined for unusual and potentially cancerous cells. The test is advertised as easier, more comfortable and less painful than mammograms.

However, there is no document to support claims that the test can detect breast cancer, said Dr David Lerner, a medical dignitary at the US Food and Drug Administration and a breast imaging specialist. "FDA's involve is that the nipple aspirate test is being touted as a standalone tool to screen for and pinpoint breast cancer as an alternative to mammography," Lerner said in an agency news release.

So "Our concern is that women will forgo a mammogram and have this test instead". Skipping a mammogram could put a woman's healthiness and life at risk if breast cancer goes undetected, Lerner warned. He said there is no regulated evidence that the nipple aspirate test, when used on its own, is an effective screening tool for mamma cancer or any other medical condition.

The test is still being studied to determine if it might be useful in combination with other methods to veil for disease. "The bottom line is that women should not rely solely on these nipple aspirate tests for the screening or diagnosis of soul cancer. Mammography is still the gold standard".

In October, 2013, Atossa Genetics pulled its nipple aspirate trial - called the ForeCYTE Breast Health Test - off the supermarket after being warned by the FDA that its claims about the test were unsubstantiated. The company claimed the assess was "literally a Pap smear for breast cancer". Pap smears are a standard assay for cervical cancer.

And Women who have had a nipple aspirate test as a form of breast cancer screening should also have a mammogram, according to screening guidelines or as recommended by their doctor. Also, they should an address to their doctor about whether additional tests are needed, the FDA said. One in eight US women will expatiate breast cancer in her lifetime naturalhealthsource.shop. The sickness is the second leading cancer killer of women in the country.